Deal: Wenger Vieli advised Avelo on closing of its seed financing round of CHF 2.2 Mio.

Avelo, a Schlieren-based start-up, has just closed its oversubscribed seed financing round of CHF 2.2 Mio. to accelerate the clinical validation of their breath collector in order to make a difference in the fight against Tuberculosis and other respiratory infections. The round was led by OCCIDENT with participation from Privilège Ventures, Sanner Ventures, Zürcher Kantonalbank and several business angels.

We acted as legal advisor to Avelo and our team included Michael Baier (Partner, Venture Capital / M&A) and Dominique Mattmann (Associate, Venture Capital / M&A) from the Wenger Vieli Start-up Desk.